R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference

R&D

Building a regenerative medicine industry: Lessons from Nort...

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.

R&D

How Japan is pioneering the future of oncology clinical tria...

Discover how Japan is leading the way in oncology clinical trials through the implementation of decentralised clinical trials

R&D

Defining success for early-stage, small biotech trials

Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.

R&D

The importance of time: Grifols seeks biomarkers for early d...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.

R&D

12 Questions with Alex Guillen

As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's rapid-growth life sciences division.